JANA HUMMEL: Open Payments
NPI 1194483065 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 18 payments from 7 companies in 2025. Trend: 2023 $200 · 2024 $463 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $190 |
| Edwards Lifesciences Corporation | 1 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: LEQVIO, SAPIEN 3 Ultra RESILIA, JARDIANCE, LifeVest, ONPATTRO, WAINUA, CAMZYOS, FARXIGA.
Industry payments across TX — which companies pay providers there.
